Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway
Abstract Background The cisplatin-resistance is still a main course for chemotherapy failure of lung cancer patients. Cisplatin-resistant cancer cells own higher malignance and exhibited increased metastatic ability, but the mechanism is not clear. In this study, we investigated the effects of Ataxi...
| Main Authors: | , , , , , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
BMC
2019-04-01
|
| 叢編: | Journal of Experimental & Clinical Cancer Research |
| 主題: | |
| 在線閱讀: | http://link.springer.com/article/10.1186/s13046-019-1161-8 |